Mineralys Therapeutics, Inc. Common Stock (MLYS) financials · $2.17B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Mineralys Therapeutics, Inc. Common Stock (MLYS) $2.17B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$170.6M | -$192.4M |
| Net Income | -$154.7M | -$177.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $661.8M | $205.9M |
| Current Assets | $661.4M | $205.4M |
| Cash & Equivalents | $172.9M | $114.1M |
| PP&E | $38.0K | $53.0K |
| Total Liabilities | $15.1M | $14.6M† |
| Current Liabilities | $15.1M | $14.6M |
| Shareholders' Equity | $646.7M | $191.3M |
| Retained Earnings | -$457.2M | -$302.5M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$142.4M | -$166.3M |
| CapEx | $15.0K | $96.0K |
| Investing Cash Flow | -$389.8M | $115.0M |
| Financing Cash Flow | $591.0M | $116.1M |
| Net Change in Cash | $58.8M | $64.8M |
| Free Cash Flow | -$142.4M | -$166.4M |
FAQ
What is MLYS P/E and revenue?
Mineralys Therapeutics, Inc. Common Stock (MLYS) $2.17B cap.
What is MLYS revenue?
MLYS income-statement cache has no revenue figure yet.
Is MLYS profitable?
Mineralys Therapeutics, Inc. Common Stock last cached net income is -$154.7M (FY2025).
What are MLYS total assets?
Mineralys Therapeutics, Inc. Common Stock last cached total assets are $661.8M (FY2025).
What is MLYS free cash flow?
Mineralys Therapeutics, Inc. Common Stock last cached free cash flow is -$142.4M (FY2025).
Not investment advice. Cached statements, not a live tape.